Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
This offer is available for new patients through March 31, 2026
The glutaminase inhibitor CB-839 (Telaglenastat) enhances the antimelanoma activity of T-cellmediated immunotherapies
Instead of escalating dosages on an arbitrary schedule, our physician-designed protocol increases or decreases doses based on a members evolving progress and side effects
Weng, F
Purchasers are responsible for compliance with all applicable federal, state, and local regulations.
2 und Askarpour et al
.jpg)
US$ 29.64
US$ 29.44
US$ 28.06
